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Following the observation  that influenza viruses  can agglutinate erythro- 
cytes from certain animal species (1), numerous reports have appeared in which 
various substances  are described that are capable of inhibiting hemagglutina- 
tion (2-16). It has also been shown (6, 9, 15-20) that under suitable conditions 
influenza viruses are able to destroy the inhibitory property of these substances. 
These naturally occurring inhibitors of hemagglutination do not possess com- 
parable inhibitory activity with respect to the infectivity of virus suspensions. 
In contrast to inhibitors of hemagglutination, it has been  shown  (21-23) 
that the capsular  polysaccharide  of Type B  FriedltLnder bacilli is capable  of 
inhibiting the multiplication of mumps virus and pneumonia virus of mice 
(PVM). Studies on the inhibition of viral multiplication by this polysaccharide 
have shown that there is no interaction between virus and bacterial polysac- 
charide (24), but rather that the inhibitor affects the host (25, 26). 
A third type of viral inhibition has been  described  by Levine and Frisch 
(27) who showed that extracts of bacteria susceptible to certain bacteriophages 
inhibited the lytic action of these viruses. Further studies of this phenomenon 
by Miller and Goebel (28) revealed that in the case of Phase II Shigdla sonr~i, 
the carbohydrate haptene of the somatic antigen reacts with the bacteriophage 
and inhibits its infectivity. 
In a preliminary note (29) it was reported that a substance obtained from 
the intestines of mice inhibits both hemagglutination and infectivity by the 
GDVII strain of Theiler's encephalomyelitis  virus of mice. The present paper 
will describe  these  studies in greater detail. In common  with the influenza 
virus inhibitors,  the intestinal inhibitor prevents viral hemagglutination, and 
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in  common with the mumps-PVM  and bacterial  virus inhibitors,  it reduces 
infectivity of GDVII virus. 
The effects observed in  vivo and in  vitro appear  to result from interaction 
between virus and inhibitor. Finally, an enzyme present in the feces of mice 
has been shown to be capable of destroying the activity of the inhibitor with a 
concomitant release of reducing sugars. 
In the accompanying paper (30)  evidence is presented which indicates that 
the inhibitor is a mucopolysaccharide. 
Materials and Methods 
Viruse.sl.--The  following viruses were used: GDVII, FA, and TO strains of Theiler's mouse 
encephalomyelitis virus; Lansing (mouse-adapted)  strain of poliomyelitis virus. A distinction 
is made between TO virus obtained directly from the feces or the intestines of mice, and TO 
virus obtained after passage in the central nervous system (CNS) of the mouse, by designating 
the former TO(I) and the latter TO(B). 
TO(I) virus was obtained from feces or small intestines of 4 to 6 week old mice. The feces 
or small intestines were homogenized with 10 volumes of distilled water. After centrifugation 
at 2500 R.P.~¢. for 15 minutes, the superaatant liquid was decanted, mixed with approximately 
one-half its volume of ether, and allowed to remain overnight in the refrigerator. The aqueous 
phase was then collected and the residual ether was removed by means of reduced pressure. 
After centrifugatlon at 2500 R.1,.~. for 15 minutes, the supernatant  liquid was decanted and 
stored. 
GDVII, FA, TO(B), and Lansing viruses were propagated by CNS passage in mice. In 
preparing the suspensions  of GDVII and FA viruses, the brains of infected mice were removed 
and homogenized with 10 volumes of distilled water. The TO(B)  and Lansing viruses were 
prepared  in  the  same manner with  the  exception that  both  brains  and  spinal  cords were 
harvested. 
Virus preparations were stored at --70°C. in a dry-ice chest. 
Mice.--The mice used in these experiments were the CFW strain obtained from Carworth 
Farms, New City, New York. 
Virus Titrat&as.--The infectivity titers of GDVII and FA viruses were determined by the 
method of Gard (31) and expressed as 1/T value. Serial dilutions of extracts of infected mouse 
brain were prepared in cold saline solution (0.85 per cent NaCl). For each virus dilution six 
lightly anesthetized mice 4 weeks of age were inoculated intracerebraliy with 0.03 ml. The mice 
were observed daily for characteristic symptoms. The 1/T valueswere computed from the equa- 
tion (31)  :~ 
11~1 +  11~ +  ...  lltN 
1IT --~ 
N 
in which ~1. • • iN are the incubation periods in individual mice and N is the total number of 
inoculated mice. Three titration curves for GDVII virus are shown in Fig. 1. 
It  can  be  seen  that  there  is  a  satisfactory  linear  relationship  between  the 
lIT values and the  logarithms  of the  dilutions  between  10  -s  and  10-  e.  These 
1GDVII virus was obtained from Dr. M. Theiler of The Rockefeller Institute for Medical 
Research; FA and Lansing viruses were obtained from Dr. R. Ward, New York University 
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results are not entirely in  agreement with  those of Gard  (31)  who reported 
proportionality over the entire range of dilutions. This disagreement may be 
due to differences in virus or mouse strains employed. In this laboratory it was 
found that with low dilutions of the virus (e.g. 10  -~, 10--2), the lIT values were 
not accurate measures of virus titer since all the test mice either showed signs 
of infection or were dead on the 2nd day after inoculation. As a rule, lIT values 
below 0.10 were found to be unreliable. 
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FIG.  1.  Relation between 1/T value and logarithm of dilution of virus. Each curve was 
obtained with a  different viral preparation (O, O, @).  Each point  represents the 1/T value 
for a group of 6 mice. 
The hemagglutinin titer of GDVII virus was determined by a modification of the method 
of Lahelle and Horsfall (32). Human group O red blood ceils (RBC) were collected aseptically 
in an equal volume of sterile Alsever's solution and kept in the refrigerator as a stock suspen- 
sion. As needed, a portion of the cells was washed with saline solution and a 0.4 per cent sus- 
pension in saline was prepared. Serial twofold dilutions of the virus were prepared in 0.5 mi. 
of saline in 10 by 75 ram. tubes. 0.5 ml. of 0.4 per cent RBC was added and the tubes kept for 
2 ~  hours in an icebath. The titer of the virus was taken as the highest dilution of the virus 
which mused complete agglutination of the RBC. This dilution was said to contain 1 hemag- 
glutinating unit (HU) per 0.5 ml. 
The infectivity titers of TO(I), TO(B),  and Lansing viruses were determined by the 50 
per cent end-point method of Reed and Muench (33). 
Inhibilor Ti~ration~.--The inhibitor was titrated in vivo by estimating its inhibitory effect 
on the infectivity of the virus as indicated by the reduction in the lIT value. In vitro, the 
inhibitor was titrated by its inhibitory effect on viral hemagglutination. 402  INHIBITION  O1~  THEILER'S  VIRUS (GDVII).  I 
In titrating the inhibitor in ~i~o, equal volumes of a solution of inhibitor and of virus, diluted 
so as to have a 1/T value of about 0.30, were mixed and 0.03 ml. inoculated intracerebrally 
into each of 6 mice. A virus control was prepared by substituting saline for the ~aibitor. From 
the virus titration curves (Fig. 1), it can be seen that a change of 0.10 in lIT corresponds to a 
change of 1 log unit in concentration of vires.  On the basis of this relationship, inhibitory 
activity was estimated by the effect on the lIT value. 
In ~itro titration of the inhibitor was carried out by preparing serial twofold dilutions of the 
inhibitor in 0.3 mh of saline. To each dilution, 0.2 ml. of virus containing 8 HU was added and 
after 30 minutes in an icebath, 0.5 ml. of erythrocytes (0.4 per cent) was added. Appropriate 
virus and erythrocyte controls were included. The tubes were kept for 2 ~j hours in an ice- 
bath. The end-point was taken as the highest dilution of inhibitor capable of causing complete 
inhibition of hemagglutination.  This dilution was said to contain 1 hemagglutiuation inhibition 
unit (HIU) per 0.3 ml. 
Preparation o:  Acetone-Dried Powder  from Tissuea.--The tissue was excised from the animal 
and minced well with scissors. Stomach and intestines, however, were first cleaned either by 
slitting open and washing  out the contents,  or by gently squeezing out the contents. The 
minced tissue was homogenized thoroughly in a Waring blendor at room temperature with 
10 volumes of acetone and centrifuged  at 2000 R.P.~. for 15 minutes.  The supematant fluid 
was discarded and the sediment was washed successively with 10 volumes of acetone and 10 
volumes of ether and finally dried in ~acuo. If the acetone-dried  powder was not extracted 
immediately, it was stored in a desiccator. 
Each acetone-dried powder was assayed for inhibitor content by extracting it with 10 vol- 
umes of saline for 1 hour at 37°C. The suspension was centrifuged and the supernatant fluid 
was titrated in ~/~o and in ~ro for inhibitory activity. 
RESULTS 
Demonstration of an Inhibitor o: GDVII Virus in Intestinal Tissue of Mice.-- 
In the course of studies on the interaction between tissues obtained from mice 
and several neurotropie viruses, it was observed that the titer of infectivity of 
Theiler's  GDVII  mouse  encephalomyelitis virus was  markedly reduced  fol- 
lowing contact with washed, minced intestine from adult mice. A  similar effect 
on viral titer was observed in the presence of brain tissue but it was less pro- 
nounced  and  not  as reproducible as with  intestinal tissue.  The  experiments 
were carried out by adding the virus to the washed, minced tissue, incubating 
for 1 hour at 5°C., centrifuging, and assaying the cell-free supematant fluid for 
viral content.  The reduction in infectivity titer of the supematant fluid sug- 
gested the possibility that virus had been adsorbed to  the tissue mince.  At- 
tempts to recover the virus from the tissue particles by elution were unsuccess- 
ful, however. 
A  reduction in titer also occurred when virus was mixed with  an aqueous 
extract of the intestinal tissue. The  chemical properties of this water-soluble 
inhibitory substance were investigated for the purpose of developing a  method 
of purification. It was  found  that  when  intestinal tissue  was  extracted with 
acetone and ether and dried, the inhibitor remained in the residue. An aqueous 
extract of this residue lost little or no activity when heated for 10 minutes at 
100°C. or when dialyzed against distilled water. Neither trichloracetic acid nor 
shaking with chloroform precipitated or inactivated the inhibitor. BENJAMIN MAN'DEL AND EFRAIM RACKER  403 
Purification of the GDVII  Viru~ Inhibitor.--Based  on the above findings a 
method for the purification of the inhibitor was developed. The method,  do 
scribed in detail in the following paper (30), involves the removal of lipids by 
organic solvents, precipitation and denaturation  of proteins by trichloracetic 
acid and shaking with chloroform, precipitation of nucleic acids with  CuSO~, 
and finally the precipitation of the inhibitor with ethanol. On the basis of the 
analytical data (30),  the inhibitor has been identified  tentatively as a  muco- 
polysaccharide. 
TABLE I 
GDVII Virus Inhibitor Content of Various Tissues of Adult Mi~e 
Tissue 
Brain and Cord 
Lung 
Heart 
Spleen 
Kidney 
Liver 
Muscle 
Stomach 
Small intestine 
Large intestine 
Hem.agglutination- 
inhibition 
HIU/&m. drywdg~ 
5,000 
5,000 
2,500 
<300 
5,000 
5,000 
2,500 
85,000 
170,000 
2,500 
Dilution 
1:40 
1:40 
1:40 
1:40 
1:40 
1:40 
1:40 
1:40 
1:400 
1:40 
1:400 
1:40 
Infectivity-inhibition 
I 
Y 
0.22 
0.17 
0.25 
0.23 
0.21 
0.23 
0.24 
0.11 
0.21 
0 
0 
0.19 
1  Virus control, 
0.24 
Biological Aaivity.--By the in vivo method it was found that 0.03 ~g. of the 
purified inhibitor reduces the 1/T value of the virus from 0.30 to between 0.20 
and 0.15.  This reduction represents neutralization  of 25  to 30 LDso of virus. 
In vitro, 0.03 to 0.06 #g. inhibits 8 hemagglutinating units of GDVII virus. 
Distribulion of the Inhibitor among  Various Tissues of Adult Mice.--A study 
was undertaken to determine the inhibitor content of various tissues of adult 
mice. 
Several mice, approximately 4 months old, were sacrificed, the following organs excised, 
and an acetone-dried powder of each prepared: brain and spinal cord, lung, heart,  spleen, 
kidney, liver, muscle, stomach, small intestine, and large intestine. Each powder was extracted 
and the individual extracts assayed for inhibitory activity. The results are recorded in Table I. 
It is clear from the data in Table I  that the inhibitory activity of the small 
intestine and stomach greatly exceeds that of any of the other specimens ex- 
amined. Although  the stomach extract contained about one-half as much in- 
hibitor  as  the  extract  of  small  intestine  as  measured  by  hemagglutination 
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infectivity. Further studies were therefore carried out only with the intestinal 
extracts. 
Comparison of the GDVII Virus Inhihitor  Content of the Intestinal  Tissue of 
Adult and Infant Mice.----Olitsky (34)  found that while he could recover TO 
virus from the  intestinal  tract  of adult  mice with  great  regularity,  he  was 
never able to demonstrate  this virus in the  intestinal  tract  of mice younger 
TABLE II 
Comparison  of GDVII Virus Inhibitor  Titers Found in the Intestinal  Tissue of 
Infant and Adult Mi~e  • 
Experiment 
No.  Age group 
Infant 
Pool 1 
Pool 2 
Adult 
Infant 
Pool 1 
Pool 2 
Adult 
Hemagglutination- 
inhibition 
HlU/gm. dry weight 
3,000 
1,600 
50,000 
6,050 
6,050 
160,000 
Infectivity-inhibition 
1  Dilution  -~ 
1:40  0.17 
1:400  0.26 
1:40  0.11 
1:400  0.22 
1:40  0.11 
1:400  0.09 
1:40  0.04 
1:400  0.17 
1:40  0.06 
1:400  0.20 
1:40  0.08 
1:400  0.08 
Virus 
control, T 
0.29 
0.28 
than 12 days of age. Because of this difference it was thought to be of interest 
to examine infant as well as adult mouse intestinal  tissue for content  of in- 
hibitor. 
Intestines from mice ranging in age from 5 to 8 days were pooled and acetone-dried powders 
prepared. Extracts of these powders were compared with extracts of acetone-dried powders 
of adult intestinal tissue. 
The results of this study which are recorded in Table II, show that the in- 
testinal tissue of adult mice contains at least 10 times as much inhibitor on a 
dry weight basis as the intestinal tissue of infant mice. BENJAMIN"  MANDEL  AND  EF~  RACKER  405 
Since these 2  groups of mice differ in respect to both age and presence of 
TO virus in the intestinal tract, a similar study was carried out with adult mice 
from a  Theiler-free mouse colony (29)  and adult mice from the regular stock 
which are intestinal  carriers of TO virus. It was found that the intestines of 
the Theiler-free mice contain inhibitor in somewhat higher concentration than 
the intestines of the virus-bearing mice. 
It can therefore be stated that the presence of a  high concentration of in- 
hibitor in the intestines is independent of the presence of TO virus. There is, 
moreover, a suggestion that TO virus in the intestinal tract is associated with a 
slight reduction in the inhibitor content. 
The GD VII Virus Inltibitor Content of the Intestinal  Tissue of Varkms Species 
o/Animal.--A  survey was  undertaken  to  determine  whether  the  intestinal 
tissue of any species of animal other than the mouse contains the GDVII virus 
inhibitor. 
Acetone-dried powders were prepared of the small intestine of the following animals: man, 
monkey, rat, cotton rat, hamster, guinea pig, rabbit, sheep, cow, and pig. The powders were 
extracted and each extract assayed. 
The data in Table III show that only guinea pig intestinal tissue contains an 
inhibitor for GDVII virus in quantity similar to that found in the intestines 
of mice. No attempts have as yet been made to characterize this inhibitor from 
guinea pig. 
The Mechanism  of the Inhibition  Reaaion.--To  explain  the  nature  of the 
hemagglutination-inhibition reaction, 2 hypotheses were considered:  (a) virus 
and  inhibitor  react  to  form  an  inactive  complex;  (b)  inhibitor  reacts  with 
erythrocytes in such a  manner as to render them inagglutinable by virus. 
To test the latter hypothesis, equal volumes of an inhibitor solution (I gg./ml.) and a  I0 
per cent red cell suspension were mixed and placed in an icebath for 2 hours. The mixture was 
then centrifuged and the supernatant fluid removed as completely as possible. The erythro- 
cytes were resuspended in saline to a concentration of 0.4 per cent and used in titration of a 
GDVII virus preparation.  The supernatant  fluid was titrated  for inhibitor content. The 
rcsults are shown in Table IV. 
The data in Table IV show that under the conditions employed in the hem- 
agglutination-inhibition  test,  the  erythrocytes  failed  to  adsorb  any  detect- 
able amounts of inhibitor, nor were the erythrocytes affected in their  capacity 
to be agglutinated by GDVII virus. This observation is incompatible with the 
hypothesis that inhibition  of hemagglutination is the result of a  reaction be- 
tween inhibitor and red cells. 
The possibility that virus and inhibitor interact was examined by studying 
the  effect of varying the period  of incubation  of the virus-inhibitor mixture 
prior to  the addition  of the red  cells.  The results of this  study are depicted 
graphically in Fig. 2 in which the titer of hemagglutination-inhibition is plotted 406  INHIBITION  OF  THEILER'S  VIRUS  (ODVII).  I 
TABLE HI 
GDVII Virus Inhibitor Contort of ~he Small Intestin6 of Animal Spexiez 
Experiment 
No.  Species 
MRS 
Monkey 
Rat 
Mouse 
Cotton  rat 
Hamster 
Guinea pig 
Mouse 
Rabbit 
Sheep 
Mouse 
Cow 
Pig 
Mouse 
Hemagglu  tination- 
inhibition 
HIU/gra. dry ~eight 
5OO 
<5OO 
1,000 
26,000 
2,600 
53,000 
53,000 
2,600 
1,300 
22,000 
1,600 
1,600 
51,000 
Infectivity-inhibition 
I 
Y 
Dilution 
1:40  0.28 
1:40  0.26 
1:40  0.23 
1:200  0.06 
1:2000  0.21 
1:40  0.23 
1:40  0.22 
1:400  0.28 
1:40  0.03 
1:400  0.12 
1:40  0.11 
1:400  0.09 
1:40  0.21 
1:40  0.35 
1:40  0.I0 
1:400  0.I0 
1:40  0.32 
1:40  0.32 
1:40  0.14 
1:400  0.II 
Virus 
1  control, ~- 
0.29 
0.28 
0.24 
0.31 
* RBC pattern was atypical and an end-point could not be read unequivocally. 
as a function of time. It can be seen that the end-point varies with the length 
of time that the virus-inhibitor mixture is held at 5°C. before addition of the 
red cells.  The finding of such a  dependence on time indicates an interaction 
between vires and inhibitor. Virus controls in the absence of inhibitor retained 
their titers undiminished throughout the period of the experiment. BENJAMTN MANDEL  AND E]~RAI~ RACKER  407 
The nature of the inhibition of viral infectivity in mice was investigated by 
varying the  order  of intmcerebral  inoculation  of virus and inhibitor  and  the 
time  intervals  between  the  2  inoculations.  When  the  first  inoculum  was  in- 
hibitor, the mice to be used to test the virus controls were injected with saline. 
TABLE IV 
Failure of Erythrocyt~s to Adsorb  the GDVII Virus Inhibitor 
Inhibitor pretreated with erythro- 
cytes ........................ 
Inhibitor control ................ 
* Titers are expressed as the red 
Inhibitor 
tlter* 
Hcma~glu- 
tinin nter* 
Erythroeytes pretreated  with in- 
hibitor.  150 
Erythrocyte control..  150 
brocal of the dilution. 
_J 
0 
0  I  2  5  4 
PERIOD  OF  INCUBATION  (HOURS) 
FIG. 2. Variation in hemagglutination-inhibition  end-point as a function of the time that 
inhibitor and virus interact at 5°C. Inhibitor (0.3 mL) and virus (0.2 ml.) were incubated for 
varying periods of time (abscissa) before addition of RBC (0.5 ml.). The ordinate represents 
the dilution (before addition  of virus and RBC)  of a  1 ~g./ml.  solution of inhibitor  at the 
titration end-point. 
When  the  interval  between  the  2  inocula was greater  than  1 hour,  separate 
virus controls were used. The results that were obtained are shown in Table V. 
The findings  recorded in Table  V  show  that  if virus  is  injected  first,  fol- 
lowed very shortly thereafter  by inhibitor,  there  is no measurable  inhibitory 
effect. If, however, the inoculation of inhibitor precedes that of virus,  the in- 
hibitory effect persists  for at  least  2  days and possibly longer.  The effect of 408  INHIBITION  0]~  THEILER'S  VIRUS  (GDVII).  I 
the inhibitor is not restricted to the site of the inoculation, since as shown in 
Experiment 1 (Table V) the 2 inoculations were made in the same site, whereas 
in Experiment 2, the inoculations were made in opposite cerebral hemispheres. 
The results of both experiments are essentially the same. The above observa- 
tions suggest that the inhibitor functions by combining with the virus and that 
this reaction is possible only when the virus is free; i.e.,  before it comes in con- 
tact with its host cell. 
To obtain more direct evidence that virus and inhibitor interact,  use was 
made of an enzyme which specifically inactivates the inhibitor without affect- 
ing either the infectivity of the virus or the  susceptibility of the host.  The 
TABLE  V 
E ffe.ct of Varying th~ Tir~s and tl~ Ord~ of Inoculation of Virus end Inhibitor 
First inoculum 
Virus 
Inhibitor 
cl 
Inhibitor 
t¢ 
cl 
~C 
Time interval 
2 minutes 
10  " 
10  " 
1 hour 
1 day 
2  " 
1 day 
2  ¢~ 
1 week 
2  " 
Second 
inoculum 
Inhibitor 
lc 
Virus 
cg 
I  Virus 
c~ 
~L 
Infectlvity-lnhibitlon 
1  virus 
1  T  control, 
0.21  0.25 
0.22 
0.10 
0.15 
0.17  0.32 
0.21  0.35 
0.13  0.31 
0.17  0.32 
0.23  0.29 
0.26  0.32 
properties of this enzyme will be described below. If the virus and inhibitor 
interact to form a  complex, centrifugation at high speed of a  mixture of the 
two should yield a deposit which is devoid of viral activity. Treatment of the 
neutralized virus by the specific  enzyme might be  expected  to  restore viral 
infectivity. 
A  mixture consisting of 6.0 ml. of I0  -s dilution of virus and 2.0 ml. of an inhibitor solu- 
tion (500 ~g./ml.) was allowed to stand for 1 hour at 5°C. and then centrifuged for 2 hours 
at  140,000  g. The  supernatant  fluid was  decanted as completely as possible. The sediment 
was  resuspended  in 8.0  ml. of saline  and  centrifuged  for  2  hours  at  140,000  g. After the 
supernatant fluid  was  discarded, the  sediment was  resuspended in  2.0  ml.  of saline.  One 
aliquot was treated with an equal volume of partially purified  2 enzyme for 1 hour at 37°C.; 
a  second aliquot was  treated  wlth heat-inactivated  enzyme. Both  specimens were  tested 
for infectivity in mice. The results are shown in Table VL 
2 The  authors wish to  thank  Mr.  Irwin Sehultz for assistance in  the purification of the 
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The data in Table VI show that the sediment from the virus-saline mixture 
had a  higher titer (0.31)  than the sediment from the virus-inhibitor mixture 
(0.20). Upon treatment of each with active enzyme, the titer of the latter in- 
creased about 100-fold (0.42), whereas the titer of the virus control remained 
the same (0.32). It is of interest that the titers of the specimens obtained from 
the virus-saline mixture were lower than the titer of the reactivated specimen. 
Since it had been determined that approximately 50 per cent of the total con- 
tent of virus had been sedimented with each centrifugation of the virus con- 
trol,  the above difference in viral activity may indicate  that the neutralized 
virus (i.e. virus-inhibitor complex) has a  greater mass and therefore a  higher 
sedimentation rate. 
TABLE VI 
Sedimento~ion from a Minute of Virus and Inh'dgtor of Paraally N~utrallzed Virus 
and Restora2$on of Viral Aaini~y by an Inhibitor-Destroying Enzyme 
1 
Values of -~  obtained with 
Dilution  Sediment from virus-inhibitor  mixture  Sediment from virus-saline mixture 
incubated 37*C./I hr. with  incubated 37"C./I hr. with 
Undiluted 
1:5 
1:25 
Active enzyme 
0.42 
0.32 
0.29 
Inactive* enzyme 
0.20 
0.11 
Active enzyme 
0.32 
0.26 
0.22 
IB~tive* euzyme 
0.31 
0.27 
0.19 
* Enzyme inactivated by heating for 10 minutes at 100°C. 
The Specificity  of the  Action  of the  GDVII  Virus  Inhibitor.--The  GDVlI 
virus inhibitor was tested for activity against several other neurotropic viruses. 
With Theiler FA virus the effect on the 1/T value was examined. In the case 
of TO(I), TO(B), and Lansing viruses the effect on the 50 per cent end-point 
(IDs0) was observed. 
Dilutions of each virus were prepared and mixed with equal volumes  of a 1 mg./ml, solution 
of purified inhibitor. The mixtures were incubated for 1 hour in the refrigerator. GDVII virus 
was included in the experiment as control. In this case, however, the concentration of the 
inhibitor was 0.01 mg./ml. The results are shown in Table VII. 
As shown in Table VII, 5/zg./ml.  of inhibitor reduced the titer of GDVII 
virus by about 2 log  dilutions, whereas  the  infectivity of the  other 4 viruses 
was unaffected by inhibitor concentrations of 500/zg./ml. 
Effect  of  Virus  Preparations  on  the  GDVII  Virus Inhibitor.--It  has  been 
shown (6, 9, 15-20) that certain viruses (e.g. influenza) are able to destroy the 
inhibitory activity of certain hemagglutination inhibitors. The possibility was 
therefore considered that those viruses which were not affected by the GDVII 
virus inhibitor might possess the power to destroy it. 410  I~IIIBITION OF  THEILER'S  VIRUS  (GDVII). I 
To test  this  possibility,  freshly  harvested virus  preparations (10 per cent extracts  of in- 
fected  CNS or  feces)  were  mixed with  an  inhibitor  solution  and incubated for  3 hours  at  37°C. 
The titer  of the inhibitor  was determined at the be#nnlng and end of the incubation period 
after  first  beating an aliquot  at loo°C, for  S minutes. Heating at this  temperature  inactivates 
the  virus  but does  not  affect  the titer  of  the  inhibitor.  The effect  on  hemagglutination-inhibition 
is  shown in  Table VIII. 
TABLE  VII 
Failure of the GDVI1 Virus Inhibitor to Act against Other Neurotropic Viruses 
Virus 
TO(I) 
TO(B) 
Lansing 
FA 
GDVII 
Concentration 
of inhibitor 
~g./ml. 
5OO 
5OO 
5OO 
5OO 
5 
IDs0 end-point 
Virus plus  Virus  control  inhibltor 
10-1.s  lO-X.s 
10-'~.4  lO..-~.s 
10--~.9  lO--a.a 
lO-~a  lO-e.~ 
I  value 
Virus plus  Virus control  inhibitor 
0.21  0.21 
0.06  0.25 
TABLE  VIII 
Effect on tie Tiler of the GDVI1 Virus InMbitor of Several Viral Preparations 
Hemsgglu  tination-inhibition 
Virus 
TO(I) ................................. 
TO(B) ................................ 
Lansing ............................... 
FA ................................... 
Normal CNS .......................... 
TO-free fecal extract .................... 
Before incubation* 
HIU/mL 
6,400 
6,400 
6,400 
6,400 
6,400 
6,400 
After incubation* 
HIU/mL 
8OO 
6,400 
6,400 
6,400 
6,400 
8OO 
* The virus-inhibitor mixtures were incubated for 3 hours at 37°C. 
As shown in Table VIII, there was no effect on the titer of the inhibitor by 
TO(B), Lansing,  and  FA viruses, nor by normal mouse CNS  tissue.  On the 
other hand, the TO(I) virus preparation, as well as a similar extract obtained 
from the feces of mice free of TO virus, caused a significant diminution in the 
titer. Since an inhibitor-destroying agent was present in the fecal extracts, no 
conclusion  regarding  inhibitor-destroying  activity  of  TO(I)  virus  could  be 
reached. 
It was therefore decided  to purify TO(I)  virus by differential centrifugation 
and to follow the inhibitor-destroying activity during purification. 
A crude 10 per cent  extract of mouse  feces was  prepared and  treated with 0.5  volume 
of ether overnight in the refrigerator. After removal of the ether, the aqueous extract was 
centrifuged for 1 hour at 32,000 g. The sediment was discarded and the supernatant fluid was BENJAMIN MANDEL  AND ElrEAIM RACKER  411 
centrifuged for 2 hours at 140,000 g. The supernatant  fluid was decanted and saved; the vi- 
res-containing pellet was suspended in ~'~o of the original volume of water. Since the hemag- 
glutination-inhibition  method of measuring inhibitory activity has a  relatively  high experi- 
mental error, a more sensitive method (discussed below) of measuring inhibitor destruction was 
employed based on the amount of reducing st/gars liberated from the mucopolysaccharide as 
a result of its destruction. Three of the above fractions were tested  for inhibitor-destroying 
activity by incubating a sample of each with the inhibitor and measuring the reducing sugars 
before and after incubation. 
TABLE IX 
Inhlbltor-Destroying Aaidty of Several Fractions Obtained during Purifwalion of 
TO(I) Virus 
Fraction  Enzymtfic activity 
t~/a/~niI** 
32,000 g supernate  250 
140,000 g supernate  169 
140, OO0 g pellet  29 
* 1 unit of enzyme liberates  1 ~ x  of reducing sugar  (as glucose) from 1 rag. of inhibitor 
in a final volume of 0.5 ml. in 1 hour at 37°C. 
Effect of a Crude Extract o 
Time of 
incubation 
370C./hrs. 
0 
1 
2 
Reducing sugars* 
mg./r~l. 
0.65 
1.01 
1.19 
TABLE X 
Mouse Feces on the GDVII Virus Inhibitor 
Hemagglutination- 
Inhibition 
HIU/ml. 
64,000 
6,400 
8OO 
Infecfivil  ,-inhibition 
1 
T 
0.04 
0.32 
•  1  V~rus control, T 
0.28 
* Expressed as glucose, determined by the method of Nelson (35). 
The data in Table IX show that all three fractions possess inhibitor-destroy- 
ing activity. After removal of the virus from the fecal extract by centrifuga- 
l.ion,  the bulk of the activity remains in the supernatant fluid. The virus-con- 
taining fraction, however, retains a low degree of activity. Whether this activity 
is  in fact associated with  the virus itself,  or is derived from the supematant 
fluid as a  contaminant cannot be decided from the above experiment. 
Enzymatic Inactivation of the GDVII  Virus Inh'~itor.--As shown above, the 
feces of mice contain an agent capable of destroying the biological activity of 
the inhibitor.  Since the available evidence (30) indicates that the inhibitor is a 
mucopolysaccharide,  an attempt  was made  to follow the  inactivation  of the 
inhibitor by measuring the change in reducing sugars as well as the reduction 
in  titer.  The  results  of a  typical  experiment  in  which  the  inhibitor  was  in- 
cubated with a  crude fecal extract are shown in Table X. 412  II~IiU~ITION  OF  THEILER'S  VIRUS  (GDVII).  I 
It can be seen that there is a progressive increase in reducing sugars as the 
hemagglutinationoinhibition  and  infectivity-inhibition titers  decrease.  When 
the inhibitor is incubated with a  fecal extract which had been heated for 30 
minutes at 56°C., the above noted changes do not occur. Incubation of the fecal 
extract without added inhibitor results in little or no change in reducing sugars. 
These results show that crude extracts of feces contain an enzyme, or enzymes, 
capable of degrading the mucopolysaccharide and reducing its inhibitory ac- 
tion. 
An attempt was made to determine if the enzyme is produced by the mi- 
crobial population of the intestinal tract of the mouse. When a fecal suspension 
was  inoculated  into  neopeptone  broth  and  incubated  anaerobically for  24 
hours at 37°C., inhibitor-destroying activity was present in the culture filtrate. 
Mter several subcultures  of the  mixed  microbial population,  enzymatic ac- 
tivity was still present. Isolation of a  single bacterial species capable of syn- 
thesizing the enzyme has not been successful. Incubation has been carried out 
in  the presence of inhibitor under aerobic and anaerobic conditions both in 
the presence and absence of COs. 
Several known  enzymes  have  been  examined for inhibitor-destroying ac- 
tivity. Crystalline trypsin, ribonuclease, lysozyme, and spleen cathepsin  ~ were 
found to be inactive. A filtrate from a culture of Vibrio cholerae was tested and 
found to be inert although it was very active in destroying the receptors on 
human  RBC for influenza virus. A preparation of commercial pancreatin was 
found to be weakly active. 
DISCUSSION 
It has been shown that some viruses, e.g. influenza, are capable of reacting 
with various naturally occurring receptor substances. The reaction appears to 
be enzymatic in nature, the enzyme being associated with the virus  particle. 
As with other enzyme reactions, there is first the formation of an enzyme-sub- 
strate complex followed by dissodation of the complex with alteration of the 
substrate. It has been shown that this course of events can be modified so that 
the formation of the  complex occurs without subsequent  dissociation.  Hirst 
(36) accomplished this by treating the enzyme (virus) with periodate, whereas 
Burnet (37) treated the substrate (receptor substance) with periodate. In the 
latter case the substrate was modified su~ciently to lose its susceptibility to 
the action of the enzyme without losing its a~nity for the enzyme. This modi- 
fied substrate  therefore behaves as an inhibitor, and Burnet has shown  (37) 
that it is capable of inhibiting infection of chick embryos with the WSE strain 
of influenza virus. 
In  the  present  instance  GDVII  virus  possesses  no  demonstrable  enzyme 
activity against  the intestinal  inhibitor.  This is perhaps  the  explanation for 
8 The authors wish to thank Dr. I. Krimsky for supplying the spleen cathepain. BEN~'AMIN MANDEL  AND E~  RACKER  413 
the rather unique property of the inhibitor of neutralizing viral infectivity as 
well as hemagglutination. Like other known inhibitors of viral hemagglutina- 
tion,  the  GDVII  virus  inhibitor  is  a  high  molecular weight mucopolysac- 
charide. 
The best source of inhibitor was found to be the small intestine of the adult 
mouse, which is also the probable site of multiplication of Theiler's TO virus. 
It was interesting to find that the same tissue obtained from infant mice which 
are free of TO virus, is a relatively poor source of inhibitor. The possibility that 
the inhibitor of GDVII virus is actually TO virus receptor substance was in- 
vestigated without a  satisfactory conclusion. Although TO virus, purified by 
high  speed  centrifugation,  contained enzymatic activity against  the  muco- 
polysaccharide, the possibility that the virus was contaminated with a  fecal 
carbohydrase  could  not be  excluded.  That  there  is  an  inhibitor-destroying 
factor independent of TO virus is clearly shown by the presence of enzymatic 
activity in  the  following preparations:  (a)  The  supernatant  fluid obtained 
after high speed centrifugation of TO virus; (b) Fecal extracts from mice free 
of TO virus; (c) Fecal extracts from human beings and rats which are free of 
TO virus. 
With the aid of the inhibitor-destroying enzyme, evidence has been obtained 
which shows that the inhibition of GDVII virus is the result of the combination 
of virus and inhibitor. The possibility should be considered that a similar reac- 
tion may occur in the case of "masked" or "latent viruses." Reactivation of a 
"masked" virus by an enzyme has been demonstrated with PVM (38). 
The  inhibitory effect of extracts of various tissues from mice on GDVII 
virus was studied by Fasfier (39).  He found that extracts of various organs 
inhibited hemagglutination but not infectivity; however, no data on intestinal 
tissue were included. 
It is of interest that Theiler's FA virus is entirely resistant to the action of 
the mucopolysaccharide inhibitor in spite of the fact that it is closely related to 
GDVII virus on the basis of complement-fixation (40) and hemagglutinafion- 
inhibition (32)  studies. Other differences in biological behavior between these 
two strains have been observed. For example, FA virus fails to grow in tissue 
culture  (41)  under conditions which support multiplication of GDVII virus 
(42). Also, FA virus inhibits carbohydrate metabolism in mouse brain, whereas 
GDVII does not (43). Finally, GDVII but not FA agglutinates human erythro- 
cytes (32). 
SUMMARY 
A  mucopolysaccharide has  been  obtained  from intestinal  tissue  of  adult 
mice which inhibits both infectivity and hemagglutinafion of Theiler's GDVII 
strain  of  encephalomyelitis virus of  mice.  The  inhibitor  is  inactive against 
the FA and TO strains of Theiler's virus and against the Lansing strain of polio- 414  INHIBITION  O:F  THEILER'S  VIRUS  (GDVII).  I 
myelitis virus. In the adult mouse, large amounts of the inhibitor are found 
only in the small intestine. The small intestine of infant mice, however, con- 
tains a  considerably smaller amount of inhibitor. Inhibition, both in vivo and 
in vitro, appears to be the result of an interaction between virus and inhibitor. 
The intestines of man, monkey, rabbit, rat, cotton rat, hamster, sheep, cow, 
and pig contain relatively little inhibitor whereas guinea pig intestine contains 
as much as adult mouse intestine. An enzyme was found in the feces of mice, 
and several other animals, which is capable of destroying the inhibitory ac- 
tivity of the mucopolysaccharide with the liberation of reducing sugars. 
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